Global Pharma 4 — March 20th 2026.

Not a course.

A mindset shift for those shaping the future of pharma.

Apply now
for the 4th Edition
 €2500

Seats are highly limited, and every application is reviewed individually by the GenH team.

We select people who will elevate the conversation.

This is a
Learn & Act Course

Our Learn & Act model combines expert-led learning with hands-on application. Participants first gain advanced insights and skills, then collaborate to tackle a real-world business case from an actual company.

Exclusive discounts for corporate groups, reach out for details.

Top Leaders at GP5

Paulo Teixeira
Paulo Teixeira Country Manager at Pfizer Portugal
Filipa Mota e Costa
Filipa Mota e Costa Managing Director at J&J Innovative Medicine Portugal
Paulo Barradas Rebelo
Paulo Barradas Rebelo President at Bluepharma
Paula Rosa
Paula Rosa Senior Director Product Strategy at Roche
Sérgio Alves
Sérgio Alves General Manager Iberia at Ascendis Pharma
Paula Martins de Jesus
Paula Martins de Jesus Medical Director at MSD
André de Aragão Azevedo
André de Aragão Azevedo Former Secretary of State for Digital Transition and Private Investor
Tarkan Dogru
Tarkan Dogru Head Technical Development Synthetic Molecules at Roche
Hugo Barbosa
Hugo Barbosa EU Customer Omnichannel Director at ViiV Healthcare
Sofia Ferreira
Sofia Ferreira Country Lead PT, UK and Nordics at Organon
André Correia
André Correia Executive VP at SERaro.pt
Ana Cadete
Ana Cadete CMC Project Leader at Sanofi
Daniel Guedelha
Daniel Guedelha Founder & CEO at GenH
João Santos Pereira
João Santos Pereira Executive Director & Associate Professor at Católica Medical School

GenH Alumni Community

You’re not just joining a program! you’re entering a global network of leaders from the world’s most impactful companies.

  • As this course is designed for extensive interaction with the Professors and the students, it requires physical presence.

  • The course is expected to start in March 2026 and take place every week on: Fridays (starting 17h00) and Saturdays (09h00-13h00).

  • Most of the sessions will be in Portuguese. There may be sessions in English, as we will also have international speakers.

  • Yes. A participation diploma will be provided at the end of the course and if the students comply with the needed requirements.

  • Yes. You do not need to be sponsored by your company to undertake this course.

  • Yes. The course is exactly designed to have lots of interactions with the senior leaders that will give the lectures.

  • No. This course was not designed to provide theoretical but mostly practical information.

  • This is a short course and not a post graduation.

“This course encourages innovation and entrepreneurship in the health sector, offering fundamental tools for any role in the Pharmaceutical Industry.”

Margarida Gaião,
Medical Science Liaison
Radioligand Therapies
at Novartis Portugal
GP1 Participant

“This course was a milestone in acquiring the most current knowledge about the Pharmaceutical Industry in Portugal and the world”

Rui Pardelha,
Territory Manager Middle East , Turkye and Africa
GP1 Participant

"Participating in this course was an incredible experience, where a diversity of colleagues from different areas inspires us to explore curiosity and creativity, to think innovatively and build solutions for better access to healthcare for our patients"

Susana Moreira,
Regulatory Affairs Manager
Spain & Portugal at Sandoz Iberia
GP2 Participant